文献速递前列腺癌肾癌与肾肿瘤膀胱癌与上尿路尿路上皮癌

癌症家族史对前列腺癌患者第二原发癌风险及死亡率的影响

Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2018-09-05

基于瑞典家庭癌症数据库的全国性队列研究纳入4.4百万男性及1990至2015年确诊的80,449例前列腺癌患者,分析家族史对第二原发癌(SPC)风险及死因的影响。结果显示有家族史者SPC相对风险为1.37(95%CI 1.27-1.40),无家族史者为1.10(1.08-1.16);SPC患者中半数死因归因于SPC,仅12.77%归因于前列腺癌。

要点

  • 前列腺癌患者中,一级亲属癌症家族史使SPC风险升高至1.37(95%CI 1.27-1.40)。
  • 至83岁时,单纯前列腺癌累积发病率为21%,合并SPC为28%,合并SPC且有家族史为35%。
  • SPC患者中半数死因由SPC导致,最常见为肺癌和结直肠癌。

核心结论

  • SPC是前列腺癌患者的重要死因,家族史是SPC的重要危险因素。
  • 在前列腺癌生存率改善的背景下,应重视SPC的预防,可从确诊时全面评估家族史开始。

研究设计与样本

  • 基于瑞典家庭癌症数据库的全国性队列研究,覆盖4.4百万男性及1990至2015年确诊的80,449例前列腺癌。
  • 计算前列腺癌患者SPC及家族性SPC的相对风险(RR)和累积发病率。

主要发现

  • 6,396例男性诊断为SPC,其中超过三分之一有一级亲属任何癌症家族史。
  • 有家族史者SPC相对风险为1.37(95%CI 1.27-1.40),无家族史者为1.10(1.08-1.16)。
  • 至83岁累积发病率:单纯前列腺癌21%,合并SPC 28%,合并SPC且有家族史35%。
  • 家族史与七种特定SPC风险相关,包括结直肠癌、肺癌、肾癌、膀胱癌、皮肤癌(黑色素瘤和鳞状细胞癌)及白血病。
  • 结直肠癌和肺癌是常见SPC,家族史使这两种SPC风险加倍。

临床怎么用

  • 前列腺癌确诊时应全面评估家族史以识别SPC高风险患者。
  • 对SPC高风险患者应加强预防和筛查,尤其关注肺癌和结直肠癌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Survival rates are increasing in patients with prostate cancer, and second primary cancers (SPCs) are becoming more common in these patients. However, the etiology and clinical consequences of SPCs are not well-known. We define the impact of family history on SPC and causes of mortality in these patients. PATIENTS AND METHODS: A nation-wide cohort study based on the Swedish Family-Cancer Database covering 4.4 million men and 80,449 prostate cancers diagnosed between 1990 and 2015. Relative risks (RRs) and cumulative incidence for SPCs and for familial SPC were calculated for prostate cancer patients. RESULTS: SPC was diagnosed in 6,396 men and more than a third of these patients had a first-degree family history of any cancer; the familial risk was 1.37 (95% CI: 1.27-1.40), compared to 1.10 (1.08-1.16), without a family history. Cumulative incidence by the age of 83 years reached 21% for prostate cancer alone, 28% in those with SPC, and 35% in patients with SPC and family history. Family history was associated with the risk of seven specific SPCs, including colorectal, lung, kidney, bladder and skin (both melanoma and squamous cell) cancers, and leukemia. Colorectal and lung cancers were common SPCs, and family history doubled the risk of these SPCs. In patients with SPC, half of all causes of death were due to SPC and only 12.77% were due to prostate cancer. Most deaths in SPC were caused by lung and colorectal cancers. CONCLUSIONS: SPCs were an important cause of death in patients with prostate cancer and family history was an important risk factor for SPCs. Prevention of SPC should be essential when prostate cancer survival rates are being improved and this could start by conducting a thorough assessment of family history at the time of prostate cancer diagnosis.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Chattopadhyay S, Hemminki O, Försti A, et al. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer. Prostate Cancer Prostatic Dis. 2018. PMID: 30185889. doi:10.1038/s41391-018-0089-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。